LAB PUblications

1: Successful Treatment of Neoplastic Fever with Oxybutynin

Yarchoan M, et al. J Palliat Med 2019. PubMed PMID: 31794374. PubMed Central

PMCID: PMC6882448.

 

 

2: Successful Treatment of Scar Pain with Scrambler Therapy

Yarchoan M, et al. Cureus 2019. PubMed PMID: 31777690. PubMed Central PMCID:

PMC6853271.

 

 

3: Correction: Recent Developments and Therapeutic Strategies against

Hepatocellular Carcinoma

Yarchoan M, et al. Cancer Res 2019. PubMed PMID: 31772073.

 

 

4: Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

Stein JE, et al. Clin Cancer Res 2019. Among authors: Yarchoan M. PubMed PMID:

31672770.

 

 

5: MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

Yarchoan M, et al. PLoS One 2019. PubMed PMID: 31671149. PubMed Central PMCID:

PMC6822709.

 

 

6: Recent Developments and Therapeutic Strategies against Hepatocellular

Carcinoma

Yarchoan M, et al. Cancer Res 2019. PubMed PMID: 31481419.

 

 

7: Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing

Checkpoint Inhibitor Therapy

Shah PP, et al. JAMA Oncol 2019. PubMed PMID: 31465106.

 

 

8: Mechanistically detailed systems biology modeling of the HGF/Met pathway in

hepatocellular carcinoma

Jafarnejad M, et al. NPJ Syst Biol Appl 2019. Among authors: Yarchoan M. PubMed

PMID: 31452933. PubMed Central PMCID: PMC6697704.

 

 

9: Immune-Related Adverse Events Requiring Hospitalization: Spectrum of

Toxicity, Treatment, and Outcomes

Balaji A, et al. J Oncol Pract 2019. PubMed PMID: 31386608. PubMed Central

PMCID: PMC6743220.

 

 

10: Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify

an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable

Survival

Danilova L, et al. Cancer Immunol Res 2019. PubMed PMID: 31043417. PubMed

Central PMCID: PMC6548624.

 

 

11: Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma

Kim AK, et al. Cancer Immunol Res 2019. PubMed PMID: 30902819.

 

 

12: PD-L1 expression and tumor mutational burden are independent biomarkers in

most cancers

Yarchoan M, et al. JCI Insight 2019. PubMed PMID: 30895946. PubMed Central

PMCID: PMC6482991.

 

 

13: Clinical and laboratory features of autoimmune hemolytic anemia associated

with immune checkpoint inhibitors

Leaf RK, et al. Am J Hematol 2019. Among authors: Yarchoan M. PubMed PMID:

30790338.

 

 

14: Development of tumor mutation burden as an immunotherapy biomarker: utility

for the oncology clinic

Chan TA, et al. Ann Oncol 2019. Among authors: Yarchoan M. PubMed PMID:

30395155. PubMed Central PMCID: PMC6336005.

 

 

15: Combining STING-based neoantigen-targeted vaccine with checkpoint modulators

enhances antitumor immunity in murine pancreatic cancer

Kinkead HL, et al. JCI Insight 2018. PubMed PMID: 30333318. PubMed Central

PMCID: PMC6237485.

 

 

16: Association between pretreatment lymphocyte count and response to PD1

inhibitors in head and neck squamous cell carcinomas

Ho WJ, et al. J Immunother Cancer 2018. PubMed PMID: 30170629. PubMed Central

PMCID: PMC6117944.

 

 

17: T cell receptor repertoire features associated with survival in

immunotherapy-treated pancreatic ductal adenocarcinoma

Hopkins AC, et al. JCI Insight 2018 - Clinical Trial. PubMed PMID: 29997287.

PubMed Central PMCID: PMC6124515.

 

 

18: Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC)

resectability: a single-center retrospective analysis

Deshwar AB, et al. Ann Pancreat Cancer 2018. PubMed PMID: 29683142. PubMed

Central PMCID: PMC5909699.

 

 

19: Histopathological and immunophenotypic features of ipilimumab-associated

colitis compared to ulcerative colitis

Adler BL, et al. J Intern Med 2018. PubMed PMID: 29464806. PubMed Central PMCID:

PMC5992029.

 

 

20: Relationships between lymphocyte counts and treatment-related toxicities and

clinical responses in patients with solid tumors treated with PD-1 checkpoint

inhibitors

Diehl A, et al. Oncotarget 2017. PubMed PMID: 29371985. PubMed Central PMCID:

PMC5768402.

 

 

21: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination

with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Shroff RT, et al. Br J Cancer 2018. PubMed PMID: 29315294. PubMed Central PMCID:

PMC5785753.

 

 

22: Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Yarchoan M, et al. N Engl J Med 2017. PubMed PMID: 29262275. PubMed Central

PMCID: PMC6549688.

 

 

23: Characterization of the Immune Microenvironment in Hepatocellular Carcinoma

Yarchoan M, et al. Clin Cancer Res 2017. PubMed PMID: 28928158. PubMed Central

PMCID: PMC5881396.

 

 

24: Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

Anagnostou V, et al. Clin Cancer Res 2017. Among authors: Yarchoan M. PubMed

PMID: 28864724. PubMed Central PMCID: PMC5735844.

 

 

25: Targeting neoantigens to augment antitumour immunity

Yarchoan M, et al. Nat Rev Cancer 2017. PubMed PMID: 28835723.

 

 

26: Olaparib in combination with irinotecan, cisplatin, and mitomycin C in

patients with advanced pancreatic cancer

Yarchoan M, et al. Oncotarget 2017. PubMed PMID: 28454122. PubMed Central PMCID:

PMC5546463.

 

 

27: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination

with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Shroff RT, et al. Br J Cancer 2017 - Clinical Trial. PubMed PMID: 28441383.

PubMed Central PMCID: PMC5520097.

 

 

28: Strategies for Increasing Pancreatic Tumor Immunogenicity

Johnson BA, et al. Clin Cancer Res 2017 - Review. PubMed PMID: 28373364. PubMed

Central PMCID: PMC5466881.

 

 

29: Targeting neoantigens to augment antitumour immunity

Yarchoan M, et al. Nat Rev Cancer 2017 - Review. PubMed PMID: 28233802. PubMed

Central PMCID: PMC5575801.

 

 

30: Association of Cancer History with Alzheimer's Disease Dementia and

Neuropathology

Yarchoan M, et al. J Alzheimers Dis 2017. PubMed PMID: 28035936. PubMed Central

PMCID: PMC5928782.

 

 

31: Ipilimumab-Induced Enteritis without Colitis: A New Challenge

Messmer M, et al. Case Rep Oncol 2016. PubMed PMID: 27920706. PubMed Central

PMCID: PMC5126596.

 

 

32: pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer

Yarchoan M, et al. Horm Cancer 2016. PubMed PMID: 26994002.

 

 

33: Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for

Long-Term Survival

Yarchoan M, et al. Cureus 2015. PubMed PMID: 26824009. PubMed Central PMCID:

PMC4725613.

 

 

34: Reply to C. Bal et al and M. Xing

Yarchoan M, et al. J Clin Oncol 2015. PubMed PMID: 26124481.

 

 

35: BRAF mutation and thyroid cancer recurrence

Yarchoan M, et al. J Clin Oncol 2015. PubMed PMID: 25422487.

 

 

36: Abnormal serine phosphorylation of insulin receptor substrate 1 is

associated with tau pathology in Alzheimer's disease and tauopathies

Yarchoan M, et al. Acta Neuropathol 2014. PubMed PMID: 25107476. PubMed Central

PMCID: PMC4304658.

 

 

37: Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease

Yarchoan M and Arnold SE. Diabetes 2014 - Review. PubMed PMID: 24931035. PubMed

Central PMCID: PMC4066335.

 

 

38: Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's

disease pathogenesis and cognition

Adler BL, et al. Neurobiol Aging 2014. PubMed PMID: 24239383.

 

 

39: Association of plasma C-reactive protein levels with the diagnosis of

Alzheimer's disease

Yarchoan M, et al. J Neurol Sci 2013. PubMed PMID: 23978419. PubMed Central

PMCID: PMC3815534.

 

 

40: Cerebrovascular atherosclerosis correlates with Alzheimer pathology in

neurodegenerative dementias

Yarchoan M, et al. Brain 2012. PubMed PMID: 23204143. PubMed Central PMCID:

PMC3577102.

 

 

41: Duplex ultrasound imaging to detect limb stenosis or kinking of endovascular

device

Blom AS, et al. J Vasc Surg 2012. Among authors: Yarchoan M. PubMed PMID:

22341834.

 

 

42: Chronic losartan administration reduces mortality and preserves cardiac but

not skeletal muscle function in dystrophic mice

Bish LT, et al. PLoS One 2011. PubMed PMID: 21731628. PubMed Central PMCID:

PMC3120761.

 

 

43: Who will manage American patients with diabetes? Residents' career

preferences and perceptions of diabetes care

Yarchoan M, et al. Endocr Pract 2011. PubMed PMID: 21041164.